Encompass Health Corp (EHC)
ROE
Obliczenia
|
2023/Q4 (31 gru 2023) |
2023/Q3 (30 wrz 2023) |
2023/Q2 (30 cze 2023) |
2023/Q1 (31 mar 2023) |
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | 349 600 | 351 600 | 312 000 | 269 800 | 269 800 | 272 400 | 326 900 | 391 100 |
| Kapitał własny | w tys. USD | 1 647 500 | 1 560 400 | 1 475 300 | 1 383 500 | 1 310 300 | 1 217 000 | 2 003 000 | 1 973 500 |
| ROE | 21,22% | 22,53% | 21,15% | 19,50% | 20,59% | 22,38% | 16,32% | 19,82% |
2023/Q4 obliczenia
ROE = Zysk netto (ttm) ÷ Kapitał własny
= $349 600K ÷ $1 647 500K
= 21,22%
Analiza porównawcza
2023/Q4
Nazwa spółki
Symbol
ROE
Encompass Health Corp
EHC
21,22%
Acadia Healthcare Company Inc
ACHC
-0,78%
Ensign Group Inc
ENSG
14,04%
HCA Healthcare Inc
HCA
—
National Healthcare Corp.
NHC
7,35%
Pediatrix Medical Group Inc
MD
-7,11%
Select Medical Holdings Corporation
SEM
18,22%
Tenet Healthcare Corp.
THC
38,00%
Universal Health Services, Inc.
UHS
11,67%